Oscar Health, Inc. filed a Form 8-K on November 16, 2026, disclosing the appointment of three new independent directors to its Board of Directors, effective November 13, 2026, expanding the board from eight to eleven members.

Key Highlights

  • Three directors appointed: Tomer Cohen, Eric Larsen, and Rajat Taneja joined the Board effective November 13, 2026.
  • Board expanded: The size of the Board increased from eight to eleven directors in connection with the appointments.
  • Committee assignments: Cohen was appointed to the Talent and Compensation Committee; Taneja was appointed to both the Audit Committee and the Nominating and Corporate Governance Committee.
  • Independence determination: The Board determined each of the three new directors qualifies as independent under New York Stock Exchange rules.
  • Initial RSU grant: Each new director is eligible for an initial restricted stock unit grant equal in value to $200,000, subject to proration, vesting on the earlier of one year from grant or the next annual stockholder meeting.
  • Annual cash retainer: The Non-Employee Director Compensation Program provides a $70,000 annual base cash retainer, plus additional amounts for committee service, paid in quarterly installments in arrears.

Oscar Health Expands Board With Three Independent Directors in November 2026

According to the filing, Oscar Health's Board of Directors appointed Tomer Cohen, Eric Larsen, and Rajat Taneja as directors on November 12, 2026, with the appointments taking effect November 13, 2026. The Board simultaneously increased its size from eight to eleven directors. Each new director is disclosed as serving a term expiring at the Company's annual meeting of stockholders to be held in 2027, and until his successor is duly elected and qualified or until his earlier death, disqualification, resignation, or removal.

The filing describes Cohen as having served as LinkedIn Corporation's Senior Vice President and Chief Product Officer from 2020 to 2026, and subsequently as an Executive Advisor. He currently teaches AI for product and business leaders at Stanford Graduate School of Business and serves on the board of Gusto. Larsen is disclosed as President of TowerBrook Advisors and a member of TowerBrook Capital Partners' healthcare leadership team since 2023, and is also identified as a senior advisor to Thrive Capital, described in the filing as Oscar Health's majority stockholder. Taneja has served as President of Technology at Visa, Inc. since 2019, and previously held senior roles at Electronic Arts, Inc. and Microsoft Corporation, according to the filing. He also serves on the board of MSCI Inc., where he chairs the Technology and Data Committee.

The filing states that each new director is eligible to receive compensation under the Company's Non-Employee Director Compensation Program. In addition to the $70,000 annual base retainer and committee retainers, the program provides for an initial RSU grant equal in value to $200,000 (subject to proration) and an annual RSU grant also equal in value to $200,000, both measured by the closing price of the Company's Class A common stock on the grant date. The Company also disclosed it expects each of the three directors to enter into the Company's standard indemnification agreement for directors and officers. The Class A Common Stock is listed on NYSE:OSCR.

What Was Disclosed

Oscar Health reported the appointment of three independent directors, an increase in Board size from eight to eleven, committee assignments for two of the new directors, and details of the Non-Employee Director Compensation Program applicable to all three appointees.